Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer

Por Ziebarth, Angela J., Nowsheen, Somaira, Steg, Adam D., Shah, Monjri M., Katre, Ashwini A., Dobbin, Zachary C., Han, Hee-Dong, Lopez-Berestein, Gabriel, Sood, Anil K., Conner, Michael, Yang, Eddy S., Landen, Charles N.
Publicado em 2012